doctor NO
NO nel DNA
doc ma allora? sta penitenza non la fai???
spari sempre MINKIATEEEEEEEEEE!!!!!!!!!!!!
quando c'azzecchi ti offro una pizza al caviale e krug
me la gusto di più se la paga il VIC
sai com'è
NicOx : Garufi ... e la Rivoluzione Pharma (6 lettori)
- Creatore Discussione Yesod
- Data di Inizio
- Stato
me la gusto di più se la paga il VIC
sai com'è
DickSIM
Prima o poi....ci becco!
me la gusto di più se la paga il VIC
ma lo sai che vic pagherà solo a 30€ poi ora con il casino che c'è stato.........non si sa nemmeno se parteciperà alle cene/pranzi. dipende da cosa deciderà la seduta plenaria del fol degli esiliati! devono dargli il nullaosta per partecipare! 
doctor NO
NO nel DNA
Hai visto c'è Guly che sbircia
vuoi vedere che ci paga i bucatini all'amatricana
lui quando arriviamo a 15€il tutto annaffiato dal vinello dei castelli romani
acqua+
ONDA NITRICA
DickSIM
Prima o poi....ci becco!
Hai visto c'è Guly che sbircialui quando arriviamo a 15€il tutto annaffiato dal vinello dei castelli romani
che fanno sbirciano e copiano?
DickSIM
Prima o poi....ci becco!
Emeryville, CA-based NovaBay Pharmaceuticals has forged a development pact with Galderma that will be worth up to $50 million in milestone payments. The development and commercialization pact covers NovaBay's Aganocide compounds and covers all major dermatological conditions, excluding onychomycosis--nail fungus--and orphan drug indications.
"This agreement highlights Galderma's commitment to the future of dermatology. Aganocide compounds have the potential to bring about significant progress in the treatment of skin diseases which affect millions of patients, without adding to the growing problem of antibiotic resistance," said Galderma CEO Humberto C. Antunes.
In the deal, Galderma takes responsibility for the development costs of the acne and other indications, except in Japan, and for the ongoing development program for impetigo, upon the achievement of a specified milestone. Galderma will reimburse NovaBay for the use of its personnel supporting the collaboration. NovaBay retains the right to co-market products resulting from the agreement in Japan. In addition, NovaBay has retained all rights in other Asian markets outside Japan, and has exclusive rights to promote the products developed under the agreement in the hospital and other healthcare institutions in North America.
Galderma was created in 1981 as a joint venture between Nestlé and L'Oréal.
"This agreement highlights Galderma's commitment to the future of dermatology. Aganocide compounds have the potential to bring about significant progress in the treatment of skin diseases which affect millions of patients, without adding to the growing problem of antibiotic resistance," said Galderma CEO Humberto C. Antunes.
In the deal, Galderma takes responsibility for the development costs of the acne and other indications, except in Japan, and for the ongoing development program for impetigo, upon the achievement of a specified milestone. Galderma will reimburse NovaBay for the use of its personnel supporting the collaboration. NovaBay retains the right to co-market products resulting from the agreement in Japan. In addition, NovaBay has retained all rights in other Asian markets outside Japan, and has exclusive rights to promote the products developed under the agreement in the hospital and other healthcare institutions in North America.
Galderma was created in 1981 as a joint venture between Nestlé and L'Oréal.
doctor NO
NO nel DNA
Cote d'azur<riviera dei fiori e BRESSO!!!!!!!!!!!!!!YOU WELLCOMEma dove le organizzate tutte queste cene? non posso venire anche io a conoscervi?....mi sembrate tipi scherzosi con la quale ci si divertira' senza ombra di dubbio........buoni cibi ...buone bevute e molte risate!!!!!!.....
- Stato